What was recalled
This page synthesizes the lysine source-form and processing-availability framework in commercial pet food. Lysine is one of nine essential amino acids for dogs and cats — the body cannot synthesize lysine de novo and must obtain it from dietary protein or supplementation. Lysine is structurally distinctive because its side chain contains a primary epsilon-amino group (rather than a hydroxyl, sulfhydryl, carboxyl, or aliphatic group like other amino acids), which makes it the most chemically reactive essential amino acid under pet food processing conditions. The epsilon-amino group is the site of Maillard reactions with reducing sugars (glucose, fructose, lactose, and reducing sugars from starch breakdown) during high-temperature extrusion and retort canning. The Maillard reaction forms early-stage Schiff base intermediates that convert to Amadori products and ultimately to advanced glycation endproducts (AGEs). Once the epsilon-amino group is bound to a sugar moiety, the lysine residue cannot be incorporated into newly synthesized protein because the modified amino acid is no longer recognized by the lysyl-tRNA synthetase.
The lysine source forms in commercial pet food include natural L-lysine from animal-tissue protein (muscle meat, fish, organ meat, eggs deliver L-lysine at 6-9% of total protein content), natural L-lysine from plant protein (legumes including soybeans, peas, lentils, chickpeas deliver 6-7% lysine per protein content; cereal grains including corn, wheat, rice deliver 2-3% lysine per protein content, making lysine the typical first or second limiting amino acid in grain-anchored formulations), and supplemental L-lysine hydrochloride (fermentation-derived synthetic monohydrochloride salt, dominant pet food premix form for balancing plant-protein-heavy formulations to AAFCO minimums). L-lysine HCl is white crystalline solid, highly water-soluble, and dimensionally stable in pet food premix conditions but participates in Maillard reactions during extrusion processing identically to natural protein-bound lysine.
The available lysine versus total lysine distinction is the structural concern. Total lysine is measured by standard amino acid analysis after acid hydrolysis of dietary protein, which liberates all lysine residues (free and Maillard-modified) and quantifies them by ion-exchange chromatography or HPLC. AAFCO compliance is measured against total lysine on this basis. Available lysine is measured by specialized methods (most commonly the furosine assay after acid hydrolysis, the reactive lysine measurement using O-methylisourea, or in vitro digestion assays) that distinguish the free epsilon-amino-group lysine from the Maillard-modified bound form. Extrusion processing typically destroys 5-20% of dietary lysine through Maillard reactions; retort canning at 121°C destroys 10-30%; baked kibble processing destroys 3-10%; raw and freeze-dried processing has minimal Maillard loss. The available lysine percentage of total lysine is therefore lower than 100% for thermally processed pet food and approaches 100% only for raw and freeze-dried formats.
Why it was recalled
The structural controversy has three layers. Layer one — AAFCO measures total lysine, not available lysine: AAFCO Nutrient Profiles specify minimum lysine concentrations as total lysine per kg dry matter measured by acid-hydrolysis amino acid analysis. The regulatory measurement does not distinguish Maillard-modified bound lysine from free epsilon-amino-group lysine. Two diets meeting AAFCO minimum on paper can deliver substantially different available lysine in vivo depending on processing intensity, reducing-sugar content of the ingredient base, and shelf-life storage conditions. The regulatory minimum is therefore not equivalent to a clinical sufficiency floor when processing-induced lysine inactivation matters.
Layer two — processing intensity drives the available / total gap: commercial-formulator literature documents 5-20% lysine destruction during extrusion, 10-30% during retort canning, 3-10% during baked kibble production, and minimal destruction during raw and freeze-dried processing. The magnitude of loss depends on barrel temperature, residence time, moisture content, and reducing-sugar load. Formulations with high glucose, fructose, lactose (from dairy ingredients), or reducing-sugar content from extensive starch breakdown produce higher Maillard loss. The implication is that two formulations meeting the same AAFCO total lysine specification can deliver substantially different available lysine depending on processing method — raw and freeze-dried products deliver close to label-stated lysine, conventional extrusion delivers ~85% of label, retort wet food delivers ~75-85% of label.
Layer three — supplementation interacts with the Maillard framework: L-lysine HCl supplementation is added to plant-protein-anchored formulations to balance the amino acid profile to AAFCO minimums. The supplemented L-lysine HCl participates in Maillard reactions during extrusion identically to natural protein-bound lysine, so the available lysine of the finished product depends on extrusion conditions and reducing-sugar exposure. A formulation that meets AAFCO minimum through plant protein plus L-lysine HCl premix and then loses 15-20% of lysine to Maillard during extrusion can deliver substantially less available lysine than label suggests. Named-meat-anchored formulations with lower supplemented lysine and lower reducing-sugar exposure typically preserve a higher available / total ratio. The extrusion heat amino acid damage controversy page covers the broader Maillard framework across multiple amino acids; lysine is the most quantitatively affected because of the reactive epsilon-amino group.
Health risks for your pet
Clinical lysine deficiency in commercial-fed dogs and cats on AAFCO-compliant diets is uncommon at the population level. Disproportionate risk concentrates in puppies and kittens during rapid growth (high lysine demand for protein synthesis, low body reserves), cats with chronic enteropathies impairing protein digestion, boutique-formulation and homemade-diet feeders without certified nutritionist oversight, and highly thermally processed wet and treat formulations with high reducing-sugar exposure where available lysine may be substantially less than total lysine on label. Clinical signs of severe lysine deficiency include growth retardation in puppies and kittens, poor coat quality, immune dysfunction, and impaired wound healing. Veterinary diagnosis is typically presumptive based on diet history and clinical response to amino acid panel supplementation.
Lysine excess from dietary sources is essentially never seen in commercial pet food; safety margins are wide and lysine is generally well-tolerated. The clinical interest in lysine excess relates to feline herpesvirus management, where L-lysine supplementation has been advocated for upper respiratory infection symptom reduction through theoretical lysine-arginine antagonism in viral replication. Recent systematic reviews of the feline herpesvirus lysine supplementation literature have called the practice into question, with several controlled trials showing no benefit and some showing potentially worse outcomes. The veterinary consensus has shifted away from routine lysine supplementation for feline herpesvirus management, though the practice persists in many veterinary settings. Pet owners should follow current veterinary guidance for individual cases rather than over-the-counter lysine supplementation without veterinary direction.
What to do if you bought affected product
Pet owners can manage lysine adequacy through several practical approaches: (1) for puppies and kittens during rapid growth, prefer named-meat-anchored growth formulations over plant-protein-heavy or highly thermally processed alternatives; the available / total lysine ratio is highest in raw and freeze-dried, intermediate in baked kibble, and lower in extruded kibble and retort wet food; (2) for adult pets on AAFCO-compliant diets, available lysine is generally adequate even in extruded kibble formats; the structural concern is more relevant for growth and pregnancy than for adult maintenance; (3) watch for reducing-sugar ingredient deck patterns — formulations with glucose syrup, dextrose, fructose, lactose (from dairy inclusion), or extensive caramel coloring contribute reducing sugars that increase Maillard lysine destruction during extrusion; (4) request available lysine specifications from brand customer service for premium and growth formulations — some brands publish available lysine on technical fact sheets even when not on consumer packaging; (5) do not over-supplement L-lysine on AAFCO-compliant complete-and-balanced diet for routine feeding; recent feline herpesvirus literature has called previously-routine L-lysine supplementation into question, and routine supplementation outside veterinary direction is not currently supported by evidence; (6) for working dogs with elevated protein demand, prefer high-meat-content formulations and consider veterinary discussion of amino acid panel adequacy if performance issues persist on AAFCO-compliant diet.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not currently differentiate available versus total lysine per our published methodology, since brand-level disclosure of available lysine specifications is essentially absent from consumer packaging (though some premium brands publish on technical fact sheets). Future rubric extension under consideration: brands publishing furosine assay or reactive lysine specifications would receive favorable scoring weight reflecting Maillard-loss transparency; raw, freeze-dried, and baked kibble formats would receive scoring credit for preserved available / total ratio relative to extruded and retort processed formats. For now, our recommendation: assume AAFCO-compliant commercial diets meet lysine adequacy for adult maintenance; for puppies and kittens during rapid growth, prefer named-meat-anchored growth formulations; treat available lysine specification as an active inquiry to brand customer service for premium formulations where the disclosure typically exists on request.